Abstract
Rats expired14CO2slightly faster when DL-phenylalanine-1-14C rather than DL-phenylalanine-3-14C was injected. An injection of DL-fluorophenylalanine-3-14C produced more radioactive CO2than did phenylalanine-3-14C; DL-beta-thienylalanine-3-14C produced only trace amounts of14CO2but significant levels of radioactivity in the urine. When an excess of one of the nonradioactive phenylalanine analogues was injected at the same time as radioactive phenylalanine, the catabolism of the radioactive amino acid was accelerated. This was shown by an increase in the radioactivity in both the CO2and urine when beta-thienylalanine or 2-amino-3-phenylbutanoic acid was used, and in the urine alone when fluorophenylalanine was used. The incorporation of radioactive phenylalanine into tissue proteins was decreased when one of the nonradioactive phenylalanine analogues was injected simultaneously. However3the incorporation into proteins of tyrosine-14C derived from injected phenylalanine-14C was increased under these conditions.
Publisher
Canadian Science Publishing
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. TePhe, a tellurium-containing phenylalanine mimic, allows monitoring of protein synthesis in vivo with mass cytometry;Proceedings of the National Academy of Sciences;2019-04-10
2. β-2-Thienylalanine effects on growth of Escherichia, Shigella, and Salmonella cultures in liquid media containing phenylalanine, tyrosine, magnesium or zinc;FEMS Microbiology Letters;1980-09
3. β-2-Thienylalanine effects on growth ofEscherichia,Shigella, andSalmonellacultures in liquid media containing phenylalanine, tyrosine, magnesium or zinc;FEMS Microbiology Letters;1980-09
4. Comparison of Liquid and Agar-Solidified Defined Media Regarding the Physiological Mechanism by which β-2-Thienylalanine Inhibits Growth ofEscherichia, Shigella, andSalmonellaCultures;Microbiology and Immunology;1980-07
5. The assay on a defined medium of the effects of β-2-thienylalanine on the growth of anaerobic bacterial isolates from phenylketonuric patients;Medical Microbiology and Immunology;1980-02